title: Phenotypic characterization of a large family with RP10 autosomal-dominant retinitis pigmentosa: an Asp226Asn mutation in the IMPDH1 gene.
abstract: OBJECTIVE
  To evaluate the clinical features associated with the RP10 form of autosomal-dominant retinitis pigmentosa in 11 affected members of various ages from one family with a defined IMPDH1 mutation (Asp226Asn).
  
  
  METHODS
  Prospective, observational case series.
  
  
  METHODS
  Visual function assessment included visual acuity, color vision, visual field, dark adaptometry, full-field electroretinography (ffERG), and multifocal electroretinography (mfERG). Ophthalmologic examinations, fundus photography, and optical coherence tomographic scans were also performed. Blood samples were obtained to screen for basic immune function.
  
  
  RESULTS
  Visual acuity was slightly reduced in the teenage years and substantially reduced in association with cystoid macular edema (CME) at all ages. Color defects were observed in three patients (one teen, two adults). Dark-adapted thresholds were elevated. Visual fields were markedly constricted by age 40 (<or=20 degrees). Rod and cone a-wave and b-wave ffERG responses were small or nondetectable by age 20, with greater rod than cone loss at all ages. The normal to significantly delayed ffERG cone b-wave implicit times in different patients were explained by their mfERG implicit times from the central retina. The amplification factors (log S) and recovery kinetics derived from the full-field rod a-waves were normal. Optical coherence tomography revealed subretinal fluid accumulation in the majority of eyes. Cystoid macular edema was diagnosed in four patients. No unusual immunologic findings were noted.
  
  
  CONCLUSIONS
  The Asp226Asn mutation is associated with a severe, early-onset form of retinal degeneration in members of this family.
authors.affiliation: Retina Foundation of the Southwest, Dallas, Texas 75231, USA. petra@retinafoundation.org
authors.forename: Petra
authors.initials: P
authors.lastname: Kozma
authors.forename: Dianna K
authors.initials: DK
authors.lastname: Hughbanks-Wheaton
authors.forename: Kirsten G
authors.initials: KG
authors.lastname: Locke
authors.forename: Garry E
authors.initials: GE
authors.lastname: Fish
authors.forename: Anisa I
authors.initials: AI
authors.lastname: Gire
authors.forename: Catherine J
authors.initials: CJ
authors.lastname: Spellicy
authors.forename: Lori S
authors.initials: LS
authors.lastname: Sullivan
authors.forename: Sara J
authors.initials: SJ
authors.lastname: Bowne
authors.forename: Stephen P
authors.initials: SP
authors.lastname: Daiger
authors.forename: David G
authors.initials: DG
authors.lastname: Birch
mesh_terms: D000293:Adolescent; D000328:Adult; D003117:Color Vision Defects / Q000235:genetics / Q000473:pathology; D004596:Electroretinography; D005260:Female; D005799:Genes, Dominant; D006801:Humans; D007168:IMP Dehydrogenase / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D020125:Mutation, Missense; D010375:Pedigree; D010641:Phenotype; D011446:Prospective Studies; D012174:Retinitis Pigmentosa / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D041623:Tomography, Optical Coherence; D014786:Vision Disorders / Q000235:genetics / Q000473:pathology; D014792:Visual Acuity; D014794:Visual Fields
chemical_list: D007168:IMP Dehydrogenase; C488211:IMPDH1 protein, human